{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:10:47Z","timestamp":1763035847722},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,4,6]],"date-time":"2004-04-06T00:00:00Z","timestamp":1081209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:p><jats:bold>Objectives:\u2002<\/jats:bold> The molecular mechanism for the regression of pregnancy pyogenic granuloma after parturition remains unclear. It has been proposed that, in the absence of vascular endothelial growth factor (VEGF), angiopoietin\u20102 (Ang\u20102) causes blood vessels to regress. Therefore, we investigated the roles of Ang\u20102 and VEGF in the regression of pregnancy pyogenic granuloma.<\/jats:p><jats:p><jats:bold>Materials and methods:\u2002<\/jats:bold> The effects of tumor necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic> (TNF\u2010<jats:italic>\u03b1<\/jats:italic>) on the transcription of Ang\u20102 were tested in endothelial cells by reverse transcriptase\u2010polymerase chain reaction. A total of 15 specimens, including granulomas taken from five gravidas during pregnancy, five after parturition, and five from normal gingiva were compared by immunoblot assays for their relative expressions of Ang\u20101, Ang\u20102, Tie\u20102, VEGF, and <jats:italic>\u03b2<\/jats:italic>\u2010actin. Double staining, immunohistochemistry for Ang\u20102, and terminal deoxynucleotidyl transferase\u2010mediated dUTP nick\u2010end\u2010labeling for apoptotic cells, were used to evaluate their regression. Finally, a fibrin gel culture system was used to investigate whether the withdrawal of VEGF and addition of Ang\u20102 could cause newly grown microvessels to regress.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> TNF\u2010<jats:italic>\u03b1<\/jats:italic> upregulated the expression of Ang\u20102 in all endothelial cell types tested. The protein levels of Ang\u20102 and Tie\u20102 were highest in the granulomas in pregnancy, followed by those after parturition and normal gingiva, while Ang\u20101 and <jats:italic>\u03b2<\/jats:italic>\u2010actin exhibited no significant differences. The amount of VEGF was high in the granulomas in pregnancy and almost undetectable after parturition. Double staining on granulomas after parturition revealed more apoptotic cells and less Ang\u20102 than did those in pregnancy. In the fibrin gel assay, VEGF alone or in combination with Ang\u20102 could protect microvessels from apoptosis, while Ang\u20102 alone had no effect.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Our findings suggest that a lack of VEGF is associated with apoptosis of endothelial cells and regression of granuloma. The roles of Ang\u20102 require additional study.<\/jats:p>","DOI":"10.1046\/j.1601-0825.2003.00997.x","type":"journal-article","created":{"date-parts":[[2004,4,6]],"date-time":"2004-04-06T15:57:19Z","timestamp":1081267039000},"page":"179-185","source":"Crossref","is-referenced-by-count":31,"title":["The roles of vascular endothelial growth factor and angiopoietin\u20102 in the regression of pregnancy pyogenic granuloma"],"prefix":"10.1111","volume":"10","author":[{"given":"K","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MT","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,6]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.3.233"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0651fje"},{"key":"e_1_2_13_4_1","first-page":"539","article-title":"A novel in vitro assay for human angiogenesis","volume":"75","author":"Brown KJ","year":"1996","journal-title":"Lab Invest"},{"key":"e_1_2_13_5_1","first-page":"3325","article-title":"Angiostatin inhibits pathological but not physiological retinal angiogenesis","volume":"42","author":"Drixler TA","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214873"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0109fje"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2109004"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5322.48"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.061"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1646"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203800"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.2296"},{"key":"e_1_2_13_14_1","first-page":"325","volume-title":"Dental management of the medically compromised patient","author":"Little JW","year":"1988"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5322.55"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.8.852"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.22.15732"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5134"},{"key":"e_1_2_13_19_1","first-page":"230","article-title":"Constitutive expression of angiopoietin\u20101 and \u20102 and modulation of their expression by inflammatory cytokines in rheumatoid arthritis synovial fibroblasts","volume":"29","author":"Scott BB","year":"2002","journal-title":"J Rheumatol"},{"key":"e_1_2_13_20_1","first-page":"135","volume-title":"Drugs, diseases, and the periodontium","author":"Seymour RA","year":"1992"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0147-0272(02)70005-6"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.6.1505"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.55.3.410"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/5.12.1141"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.8.793"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780067"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(01)00163-5"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2002.73.7.701"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1601-0825.2003.00997.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1601-0825.2003.00997.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T04:10:47Z","timestamp":1696997447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1601-0825.2003.00997.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1046\/j.1601-0825.2003.00997.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1601-0825.2003.00997.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,6]]}}}